DALLAS RINDFLEISCH: Open Payments
NPI 1073834974 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 34 payments from 13 companies in 2025. Trend: 2023 $543 · 2024 $650 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $153 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| Vanda Pharmaceuticals Inc. | 5 | $102 |
| ABBVIE INC. | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Indivior Inc. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Amgen Inc. | 2 | $32 |
| QOL Medical, LLC | 1 | $24 |
| Novo Nordisk Inc | 1 | $17 |
Products named: AIRSUPRA, Auvelity, FANAPT, VRAYLAR, REXULTI, SUBLOCADE, LEQVIO, Sucraid.
Industry payments across ID — which companies pay providers there.
